A vaccine administered during pregnancy in the United Kingdom has been shown to reduce hospital admissions of newborns for respiratory syncytial virus (RSV) infections by nearly 85%, according to UK health officials.The vaccine, introduced in 2024, is offered to pregnant women from 28 weeks of pregnancy to protect their babies from RSV, a virus that causes severe chest infections in infants.RSV affects many babies in their first months of life, with over 20,000 hospital admissions annually in the UK.The virus can cause symptoms ranging from mild colds to life-threatening lung inflammation.The vaccine boosts maternal immunity, which is passed to the... [Continue Reading]